| Year; no. of patients* | ||||
|---|---|---|---|---|
| Characteristic | 2008 | 2009 | 2010 | All years |
| No. of patients | ||||
| Eligible | 43 | 37 | 43 | 123 |
| Did not receive chemotherapy | 8 | 11 | 3 | 22 |
| With evaluable data | 35 | 26 | 40 | 101 |
| Age, yr, median (IQR)† | 50 (38.5–59.5) | 49 (39.0–58.3) | 43.5 (36.0–60.3) | 48 (37.0–60.0) |
| Sex, male, no. (%)† | 20 (57) | 18 (69) | 21 (52) | 59 (58) |
| Underlying disease† | ||||
| Acute myeloid leukemia | 24 | 21 | 32 | 77 |
| Acute lymphocytic leukemia | 8 | 5 | 7 | 20 |
| Biphenotypical acute leukemia | 3 | 0 | 1 | 4 |
| Total | 35 | 26 | 40 | 101 |
| Courses of remission–induction chemotherapy | ||||
| 1 course | 31 | 17 | 27 | 75 |
| 2 courses | 3 | 6 | 10 | 19 |
| 3 courses | 1 | 1 | 3 | 5 |
| 4 courses | 0 | 2 | 0 | 2 |
| Total no. of courses | 40 | 40 | 56 | 136 |
Note: IQR = interquartile range. *Except where otherwise indicated. †For patients with evaluable data.